Pylopass contains patented strain L. reuteri DSM 17648, designed to target specific stomach bacteria. The strain has been put through 5 clinical trials to prove its safety and effectiveness. Each capsule delivers 5 billion CFU of the L. reuteri strain and is acid resistant.
This product is hypoallergenic / does not contain any of the 14 major allergens listed in Annex II (1169/2011) of the EU Food Information for Consumers Regulation.
Directions: Take two capsules twice per day with 200ml liquid immediately before or during solid meals or as directed by your health practitioner. L. reuteri DSM17648 contains an inactivated strain of Lactobacillus reuteri DSM 17648. Suitable for children 4 years and above.